FDA Inspection 1119010 — Florida Institute for Reproductive Medicine
The FDA completed an inspection of Florida Institute for Reproductive Medicine on January 6, 2020 in Jacksonville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 6, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Jacksonville, FL (United States)